Recent Blog Posts
Long COVID in Children and Teenagers
The PostAcute Sequelae of SARSCoV-2 (PASC) The COVID-19 pandemic has caused widespread devastation, with the immediate and short-term effects of SARS-CoV-2 infection now well described. While most people recover, many experience longer-lasting effects known as long...
Development of Global Precision Medicine: Pharmalys Ltd at the EU-Africa PerMed Workshop 2024
EU-Africa PerMed (Building Links Between Europe and Africa in Personalised* Medicine) is an international project funded by the European Commission’s Horizon 2020 programme. Its goal is to integrate more African countries into the global Precision Medicine (PM)...
New WHO Guidance on Best Practices for Clinical Trials
The clinical trial landscape has undergone significant changes since the concept of trials was first introduced, with notable shifts in the social, ethical, and regulatory environments worldwide. The Clinical Trial Landscape Is Evolving Today, there is a broader...
Unlocking Africa’s Potential in Clinical Research for Global Health Impact
Figure 1. Number of clinical trials by year, country, WHO region and income group (1999-2022). Source: World Health Organisation (February 2023). The global landscape of clinical research (CR) has experienced substantial growth, with thousands of clinical...
#CountAfricaIn: Strengthening the Clinical Research Ecosystem
In recent years, the global landscape of clinical research (CR) has been evolving, with Africa emerging as a vital player in this field. Despite being home to a wealth of diverse populations and disease burdens, the continent remains underrepresented in clinical...
Newsletter September 2024
A Year of Growth and Discovery: Reflections from a Clinical Project Manager at Pharmalys Ltd Pharmalys Ltd is a regional Contract Research Organisation (CRO) that has seen significant growth over the past three years. Headquartered in Europe with regional offices in...
Precision Medicine: An Introduction to Umbrella and Basket Trials
Example of a real umbrella trial. Study scheme of the lung cancer master protocol (Lung-MAP–NCT03851445) trial. From Ouma L.O. et al. (2022) Front. Med. 9:1037439. doi: 10.3389/fmed.2022.1037439 In recent decades, cancer treatment has evolved from relying on...
A Year of Growth and Discovery: Reflections from a Clinical Project Manager at Pharmalys Ltd
Pharmalys Ltd is a regional Contract Research Organisation (CRO) that has seen significant growth over the past three years. Headquartered in Europe with regional offices in Dakar, Pharmalys supports sponsors around the world in conducting safe and high-quality...
Call for Public Review: Updated Guidance on Inclusive Language in Medical and Scientific Publications
In the realm of medical and scientific publishing, the precision and respect embedded in our language are crucial. The choice of terminology when describing individuals and groups can profoundly influence the clarity and fairness of our communications. Inclusive...
Newsletter July 2024
Pharmalys Ltd: Our Commitment to Quality As an international Contract Research Organisation (CRO), Pharmalys Ltd has always been dedicated to delivering excellence in every service we provide, ensuring quality at every step. Our Business Excellence and Quality...